We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · May 20, 2020

An Investigational Insulin Delivery Device Providing Basal/Bolus Therapy With Rapid-Acting or Regular Human Insulin in T2D

Diabetes Technology & Therapeutics

 

Additional Info

Diabetes Technology & Therapeutics
Safety and Effectiveness of an Investigational Insulin Delivery Device Providing Basal/Bolus Therapy With Rapid-Acting or Regular Human Insulin in Adults With Type 2 Diabetes
Diabetes Technol. Ther. 2020 May 01;22(5)352-359, R Aronson, E Mahoney, D Saliu, D Sze, D Morel, L Bergquist, L Hirsch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading